An interventional study of different methods of partner notification and partner delivered meds in Trichomoniasis, sponsored by University of Alabama at Birmingham. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2009-08-12.
Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Prevention
This study is designed to try to find the best method of partner notification and treatment for partners of women with trichomonas
To carry out a randomized trial to compare the effectiveness of three methods of partner notification and treatment for sexual partners of women with vaginal trichomoniasis - patient self-referral of partners (the current practice standard), delivery of curative therapy to partners by patients themselves, or public health style Disease Intervention carried out by a specially trained Disease Intervention Specialists (DIS) locating the partners and delivering the medication in the field. Reinfection rates with trichomonas at three months of follow-up among the index women will be the measure of effectiveness.
32 studies on the registry are indexed under Trichomonas Infections; 5 are open to participants now.
This study's enrollment of 599 is above the median of 270 across 19 interventional studies indexed under Trichomonas Infections.
Browse Trichomonas Infections studies →University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.
Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Inclusion criteria {for Women}:
Age {> 15 years} Culture or wet prep proven T. vaginalis infection Willingness to provide informed consent and take part in study procedures
-
Exclusion Criteria:
Infection with other STD pathogens requiring Health Dept DIS intervention (syphilis or HIV) Pregnancy or currently breast feeding Recent (8 hours) ingestion of alcoholic beverages or intent to do so in the 24 hours following treatment Allergy to metronidazole The presence of a sexual partner in the clinic at the time of enrollment A history of referral by a partner already treated for trichomoniasis Report of more than four sexual partners in the preceding 30 days
patient told to refer her partner for treatment
Other: different methods of partner notification · Other: partner delivered meds · Other: field intervention
patient given medication to deliver to her partners
Other: partner delivered meds · Other: field intervention
field intervention to find partners
Other: field intervention
comparing patient referral, partner delivered medications and field intervention to treat sex partners
patient given meds to give to her partner
health worker finds partners
recurrence of trichomonas in the index patient
Time frame: 6 weeks
This study is completed, as verified in Aug 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Alabama at Birmingham